SLC16A1 and neoplasm: Inhibition of the lactate transporter MCT1 in the syngeneic 4T1 TNBC mouse model reduced lactate efflux and tumor growth, accompanied by an increased frequency of NKG2D/perforin/CD107a-expressing NK cells with improved cytotoxicity.